Bruno Granwehr
0000-0002-5143-6416
Publication & Citation Trends
Publications
0 total
CBT and rehabilitation improved long COVID symptoms
Cited by 0
Semantic Scholar
In mild to moderate COVID-19, VV116 safely reduced time to sustained clinical symptom resolution
Cited by 1
Semantic Scholar
In complicated UTIs, cefepime–taniborbactam increased treatment success vs. meropenem at 19 to 23 d
Cited by 0
Semantic Scholar
Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. OA
Cited by 2
Semantic Scholar
False-Reactive Fourth-Generation Human Immunodeficiency Virus Testing in Cancer Patients. OA
Cited by 3
Semantic Scholar
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship OA
Cited by 8
Semantic Scholar
Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID) OA
Cited by 6
Semantic Scholar
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors
Cited by 9
Semantic Scholar
Research Topics
Hepatitis C virus research
(17)
Influenza Virus Research Studies
(11)
Hepatitis B Virus Studies
(11)
Respiratory viral infections research
(9)
COVID-19 and healthcare impacts
(9)
Affiliations
University of Iowa
Michael E. DeBakey VA Medical Center
The University of Texas MD Anderson Cancer Center
Harvard University
Bayer (United States)